Stock Performance Overview
- Opening Price: $44.78
- Current Price: $44.84
- Intraday High: $44.95
- Intraday Low: $44.56
- Trading Volume: 183,514 shares
- Average Volume: 3,296,212 shares
- Market Capitalization: $107.167 billion
- Price/Earnings (P/E) Ratio: 19.41
- Earnings Per Share (EPS): $2.31
- Beta (5Y Monthly): 0.28
- Dividend: $2.42 (5.42% yield)
- Ex-Dividend Date: May 4, 2026
- 1-Year Target Estimate: $55.90
- 52 Week Range: $42.33 - $53.03
Market Activity
As of the latest available data on June 3, 2026, Sanofi's stock is trading up by 0.38% compared to the previous close. The stock demonstrated relatively stable performance throughout the day, with minor fluctuations between an intraday high of $44.95 and an intraday low of $44.56. The trading volume of 183,514 shares is significantly below the average volume of 3,296,212 shares, indicating a quieter trading session relative to typical market activity.
Company Background
Sanofi is a global biopharmaceutical company specializing in the research, development, and marketing of therapeutic solutions. Its portfolio covers a wide range of medical areas including immunology, neurology, oncology, and vaccines. This diversified product base positions Sanofi as a major player within the healthcare sector, catering to various medical needs worldwide.
Recent Developments
There were no specific news articles, press releases, or notable announcements related to Sanofi on June 3, 2026. The absence of fresh news or events suggests a period of stability for the company’s stock, as market movements typically respond to new information. This lack of news may have contributed to the relatively low trading volume and modest price changes observed today.
Conclusion
On June 3, 2026, Sanofi's stock experienced a slight increase of 0.38%, reflecting a stable trading environment. The stock price remained within a narrow range and trading volume was well below average, indicating subdued investor activity. The lack of significant news or company events likely contributed to this calm market behavior, allowing investors to focus on Sanofi’s underlying financial fundamentals without external disruptions.
Moving forward, investors and stakeholders should continue monitoring relevant financial news and market reports to stay informed of any developments that could impact Sanofi’s stock performance.
Explore more exclusive insights at nextfin.ai.
